LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates News-Medical.net Post navigation Double killer roamed shopping centre armed with knives before fatal Melbourne attacks – The Age Tight vaccine supply spells ‘very vulnerable’ winter for Victorians – Sydney Morning Herald